Can oligodendrocyte transcriptional factor-2 (Olig2) be used as an alternative for 1p/19q co-deletions to distinguish oligodendrogliomas from other glial neoplasms? (original) (raw)

Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors

Jennifer Chan

Proceedings of the …, 2001

View PDFchevron_right

OLIG2 as a specific marker of oligodendroglial tumour cells

Michèle Kujas

The Lancet, 2001

View PDFchevron_right

Genetic markers in oligodendroglial tumours

gorazd bunc

Radiology and Oncology, 2010

View PDFchevron_right

Expression of Oligodendroglial and Astrocytic Lineage Markers in Diffuse Gliomas

Moonjoo Han

Journal of Neuropathology and Experimental Neurology, 2006

View PDFchevron_right

Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells

María Lucinda Aguirre Cruz

Journal of Neurosurgery, 2003

View PDFchevron_right

Molecular profile of tumors with oligodendroglial morphology: Clinical relevance

Bimal Patel

Neurology India

View PDFchevron_right

Assessment of 1p/19q status by fluorescencein situhybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors

Ashutosh Halder

Neurology India, 2009

View PDFchevron_right

Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study

Lucinda Aguirre

Annals of Diagnostic Pathology, 2008

View PDFchevron_right

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization

ROGER MCLENDON

American Journal …, 1999

View PDFchevron_right

Gene expression in oligodendroglial tumors

Peter Warnke

Cellular Oncology, 2011

View PDFchevron_right

Molecular markers that identify human astrocytomas and oligodendrogliomas

Dennis Pearl

Journal of neuropathology and experimental neurology, 2002

View PDFchevron_right

Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors

pankaj pathak

Neurology India, 2009

View PDFchevron_right

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas

Jerome Honnorat

Nature Communications, 2016

View PDFchevron_right

Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas

Mathilde Kouwenhoven

Cancer Research, 2005

View PDFchevron_right

Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression

Lina Núñez

Journal of Neuro-Oncology, 2009

View PDFchevron_right

Nogo-A: A useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion

Gianluca Marucci, Maria Foschini

Human Pathology, 2012

View PDFchevron_right

Oligodendroglioma: pathology, molecular mechanisms and markers

Martin Van Den Bent

Acta Neuropathologica, 2015

View PDFchevron_right

Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?

Macoura GADJI

Cancer Genetics and Cytogenetics, 2009

View PDFchevron_right

Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification

Michèle Kujas

Cellular Oncology, 2011

View PDFchevron_right

Recent developments in the molecular characterization and treatment of oligodendroglial tumors

Martin Van Den Bent

Neuro- …, 2003

View PDFchevron_right

Oligodendrogliomas: Molecular Biology and Treatment

Martin Van Den Bent

The Oncologist, 2009

View PDFchevron_right

Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic

Ying Mao

Oncotarget, 2016

View PDFchevron_right

Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH)

Martin Van Den Bent

The Journal of Pathology, 1999

View PDFchevron_right

Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas

Chao You

Acta Neuropathologica, 2007

View PDFchevron_right

Expression of oligodendrocyte-associated genes in cell lines derived from human gliomas and neuroblastomas

Anthony Campagnoni

Cancer research, 1993

View PDFchevron_right

1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis

Franck Sturtz

Modern Pathology, 2010

View PDFchevron_right

Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas

Andrew Bollen

BMC clinical pathology, 2005

View PDFchevron_right

Correlation of Molecular Genetics with Molecular and Morphological Imaging in Gliomas with an Oligodendroglial Component

Sobhan Vinjamuri

Clinical Cancer Research, 2004

View PDFchevron_right

Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study

Chiara Molinari

International journal of molecular medicine, 2010

View PDFchevron_right

Real-Time Quantitative PCR Analysis of Gene Dosages Reveals Gene Amplification in Low-Grade Oligodendrogliomas

Manuel Gutierrez

American Journal of Clinical Pathology, 2005

View PDFchevron_right